3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
7
Lymphoma, B-Cell
5
Lymphoma
5
Rhabdoid Tumor
3
Neoplasms
3
Medulloblastoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pinealoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Germ Cell and Embryonal
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Ganglioneuroblastoma
2
Ependymoma
2
Enteropathy-Associated T-Cell Lymphoma
2
Brain Neoplasms
2
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Interventions
Whole-Body Irradiation
4
Peripheral Blood Stem Cell Transplantation
4
Etoposide
4
Busulfan
4
fludarabine phosphate
3
Mycophenolic Acid
3
Cyclophosphamide
3
Transplantation
2
Tacrolimus
2
Sirolimus
2
Melphalan
2
Cyclosporine
2
fludarabine
1
aldesleukin
1
Whole Genome Sequencing
1
Valganciclovir
1
Tyrosine Kinase Inhibitors
1
Tissue Banks
1
Therapeutics
1
Self Care
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiography, Panoramic
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Methotrexate
1
Idarubicin
1
Ganciclovir
1
Foscarnet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Congenital Abnormalities
×
etoposide phosphate
×
1 year
×
Clear all
No trials found.